College of Pharmacy, Chosun University, 309 Pilmun-daero, Dong-gu, Gwangju, 61452, South Korea.
Division of Pharmacology, Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, 16419, South Korea.
Arch Pharm Res. 2019 Dec;42(12):1031-1039. doi: 10.1007/s12272-019-01196-z. Epub 2019 Nov 30.
Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter that is required for the control of synaptic excitation/inhibition and neural oscillation. GABA is synthesized by glutamic acid decarboxylases (GADs) that are widely distributed and localized to axon terminals of inhibitory neurons as well as to the soma and, to a lesser extent, dendrites. The expression and activity of GADs is highly correlated with GABA levels and subsequent GABAergic neurotransmission at the inhibitory synapse. Dysregulation of GADs has been implicated in various neurological disorders including epilepsy and schizophrenia. Two isoforms of GADs, GAD67 and GAD65, are expressed from separate genes and have different regulatory processes and molecular properties. This review focuses on the recent advances in understanding the structure of GAD, its transcriptional regulation and post-transcriptional modifications in the central nervous system. This may provide insights into the pathological mechanisms underlying neurological diseases that are associated with GAD dysfunction.
γ-氨基丁酸(GABA)是一种主要的抑制性神经递质,对突触兴奋/抑制和神经振荡的控制至关重要。GABA 由谷氨酸脱羧酶(GADs)合成,GADs 广泛分布,定位于抑制性神经元的轴突末梢,以及胞体和(程度较轻的)树突。GADs 的表达和活性与 GABA 水平以及抑制性突触随后的 GABA 能神经传递密切相关。GADs 的失调与包括癫痫和精神分裂症在内的各种神经疾病有关。两种 GAD 同工型,GAD67 和 GAD65,由不同的基因表达,具有不同的调控过程和分子特性。这篇综述重点介绍了近年来在中枢神经系统中对 GAD 结构、转录调控和转录后修饰的理解的最新进展。这可能为与 GAD 功能障碍相关的神经疾病的病理机制提供深入了解。